香港將在聖誕節前公佈略微放寬的SPAC框架,最快1月實行
《信報》援引未具名知情人士的話報道,香港交易所的特殊目的收購公司(SPAC)諮詢結果有望在聖誕節前出爐,並於明年初、最快1月實行。
港交所將會微調建議內容,包括:
1、原本需要有30名機構專業投資者參與的要求或會放寬,相關數目會被下調;
2、原禁止發行的權證合計會令行使後所獲得的股份多於權證發行時已發行股份數目的30%,據悉相關攤薄上限或會調高至50%,與新加坡的規則看齊;
3、計劃不再把SPAC股份贖回與投票決定綁死,即投票支持de-spac股份,也可進行贖回;
投資者資格方面,據悉證監會只容許專業投資者認購和買賣SPAC股份,故此,放寬至散戶參與的意見料不獲接納。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.